Enzalutamide (formerly MDV3100) prolongs survival in docetaxel-pretreated castration-resistant prostate cancer patients

por Heck, Matthias M., Gschwend, Jürgen E., Retz, Margitta
Publicado 2013

Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer

por Lunger, Lukas, Tauber, Robert, Feuerecker, Benedikt, Gschwend, Jürgen E., Eiber, Matthias, Heck, Matthias M.
Publicado 2021

EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer

por Falkenbach, Fabian, Ambrosini, Francesca, Tennstedt, Pierre, Eiber, Matthias, Heck, Matthias M., Preisser, Felix, Graefen, Markus, Budäus, Lars, Koehler, Daniel, Knipper, Sophie, Maurer, Tobias
Publicado 2023

Development and external validation of a multivariable [(68)Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cance...

por Muehlematter, Urs J., Schweiger, Lilit, Ferraro, Daniela A., Hermanns, Thomas, Maurer, Tobias, Heck, Matthias M., Rupp, Niels J., Eiber, Matthias, Rauscher, Isabel, Burger, Irene A.
Publicado 2023

Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with...

por Falkenbach, Fabian, Knipper, Sophie, Koehler, Daniel, Ambrosini, Francesca, Steuber, Thomas, Graefen, Markus, Budäus, Lars, Eiber, Matthias, Lunger, Lukas, Lischewski, Flemming, Heck, Matthias M., Maurer, Tobias
Publicado 2023

Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer...

por Thalgott, Mark, Rack, Brigitte, Eiber, Matthias, Souvatzoglou, Michael, Heck, Matthias M., Kronester, Caroline, Andergassen, Ulrich, Kehl, Victoria, Krause, Bernd J., Gschwend, Jurgen E., Retz, Margitta, Nawroth, Roman
Publicado 2015

Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer

por Thalgott, Mark, Horn, Thomas, Heck, Matthias M, Maurer, Tobias, Eiber, Matthias, Retz, Margitta, Autenrieth, Michael, Herkommer, Kathleen, Krause, Bernd J, Gschwend, Jürgen E, Treiber, Uwe, Kübler, Hubert R
Publicado 2014

KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy

por Lunger, Lukas, Retz, Margitta, Bandur, Miriam, Souchay, Marc, Vitzthum, Elisabeth, Jäger, Marion, Weirich, Gregor, Schuster, Tibor, Autenrieth, Michael, Kübler, Hubert, Maurer, Tobias, Thalgott, Mark, Herkommer, Kathleen, Koll, Florestan, Gschwend, Jürgen E., Nawroth, Roman, Heck, Matthias M.
Publicado 2020

Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment

por Harke, Nina N., Wagner, Christian, Hermann, Robert M., Hadaschik, Boris A., Radtke, Jan Philipp, Altay-Langguth, Alev, Aufderklamm, Stefan, Bach, Christian, Becker-Schiebe, Martina, Blana, Andreas, Bruns, Frank, Buse, Stephan, Combs, Stephanie E., Engels, Christina L., Ezzibdeh, Emad, Fiedler, Marcel, Fischer, Laura-Anna, Farzat, Mahmoud, Frismann, Alexander, Heck, Matthias M., Henkenberens, Christoph, Roesch, Marie C., Käding, Christoph, Klautke, Gunther, Krausewitz, Philipp, Kuczyk, Markus A., Leitsmann, Conrad, Lettmaier, Sebastian, Mahjoub, Samy, Manseck, Andreas, Medenwald, Daniel, Meyer, Andreas, Micke, Oliver, Moritz, Rudolf, Ott, Marcel, Peters, Inga, Pokupic, Sasa, Porres, Daniel, Preisser, Felix, Reichel, Kathrin, Schneider, Andreas, Schwentner, Christian, Scobioala, Sergiu, Truss, Michael, Wegener, Daniel, Wezel, Felix, Willborn, Kay, Witt, Jörn H., Wittig, Andrea, Wittlinger, Michael, Wolff, Hendrik A., Zimmermanns, Volker, Christiansen, Hans
Publicado 2022